Copyright
©The Author(s) 2003.
World J Gastroenterol. Sep 15, 2003; 9(9): 1940-1945
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.1940
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.1940
Table 4 Inhibitory effect of pCH510 + Hsp70-H22 antigen peptide complex on murine tumor
| Group | n | 105 H22 cells inoculation | 106 H22 cells inoculation | ||
| Dissecting time (d) | Tumor weight (g, -x±s) | Dissecting time (d) | Tumor weight (g, -x±s) | ||
| Control | 8 | 14 | 3.24 ± 1.22 | 10 | 3.45 ± 1.31 |
| pCH510 plasmid | 8 | 21 | 2.38 ± 0.84 | 21 | 2.72 ± 1.28 |
| Hsp70-H22 peptide | 8 | 21 | 1.44 ± 0.45 | 21 | 2.58 ± 0.93 |
| Hsp70-H22 peptide + pCH510 | 8 | 21 | 0b | 21 | 1.76 ± 0.66a |
-
Citation: Zhang GM, Yang Y, Huang B, Xiao H, Li D, Feng ZH. Experimental study on therapeutic effect of
in vivo expression of Cell I-Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma. World J Gastroenterol 2003; 9(9): 1940-1945 - URL: https://www.wjgnet.com/1007-9327/full/v9/i9/1940.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i9.1940